tradingkey.logo
搜尋

AtriCure Inc

ATRC
添加自選
31.290USD
+1.560+5.25%
交易中 美東報價延遲15分鐘
1.56B總市值
虧損本益比TTM

關於 AtriCure Inc 公司

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc簡介

公司代碼ATRC
公司名稱AtriCure Inc
上市日期Aug 05, 2005
CEOCarrel (Michael H)
員工數量1300
證券類型Ordinary Share
年結日Aug 05
公司地址7555 Innovation Way
城市MASON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編45040
電話15137554100
網址https://www.atricure.com
公司代碼ATRC
上市日期Aug 05, 2005
CEOCarrel (Michael H)

AtriCure Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%

常見問題

AtriCure Inc的前五大股東是誰?

AtriCure Inc的前五大股東如下:Mr. Michael H. (Mike) Carrel, CPA

有多少機構持有AtriCure Inc(ATRC)的股份?

截至2026Q1,共有505家機構持有AtriCure Inc的股份,合計持有的股份價值約為48.18M,占公司總股份的95.14% 。與2025Q4相比,機構持股有所增加,增幅為-7010307.00。

哪個業務部門對AtriCure Inc的收入貢獻最大?

在2026Q1,Appendage Management-United states業務部門對AtriCure Inc的收入貢獻最大,創收178.13M,占總收入的33.32% 。